« FDA: Chicago-area sandwich manufacturer agrees to stop production The U.S. | Main | FDA Approvals - FDA outlines flexible approaches for artificial pancreas system clinical trials, »

FDA Approvals - Santarus Submits New Drug Application to FDA for UCERIS (budesonide)


Santarus Submits New Drug Application to FDA for UCERIS (budesonide) Tablets
Santarus, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking market approval for UCERIS Tablets 9 mg for the induction of remission of mild to moderate active ulcerative colitis.
 

©2006 FDA-News.com. All rights reserved.